Trials / Completed
CompletedNCT01885156
Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Merz North America, Inc. · Industry
- Sex
- All
- Age
- 12 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
To see how well Naftin 1% cream works when applied once daily to the affected area. The results will be compared to those using a placebo cream, which is a cream with no active ingredient. Safety will also be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Naftin 1% Cream | Topically applied once a day |
| DRUG | Placebo Cream | Topically applied once a day |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2013-06-24
- Last updated
- 2015-04-15
Locations
5 sites across 3 countries: Belize, Dominican Republic, Honduras
Source: ClinicalTrials.gov record NCT01885156. Inclusion in this directory is not an endorsement.